Literature DB >> 16798901

Application of power Doppler vocal fremitus sonography in breast lesions.

Min Jung Kim1, Eun-Kyung Kim, Ji Hyun Youk, Ji Young Lee, Byung Moon Kim, Ki Keun Oh.   

Abstract

OBJECTIVE: The purpose of this study was to illustrate the method and use of power Doppler vocal fremitus (PDVF) sonography in the detection and diagnosis of breast lesions.
METHODS: One case was evaluated by various sonographic parameters and equipment to determine how the VF images were affected. Cases illustrative of a broad range of breast conditions were also collected. Each image pair consisted of B-mode and VF images to maintain an identical projection and to illustrate the influence of PDVF sonography.
RESULTS: With B-mode and PDVF sonography, we evaluated and compared various breast conditions, including normal anatomic structures and abnormal lesions. We found that PDVF sonography is useful for distinguishing abnormal masses from normal tissue, such as differentiating between isoechoic tumors and isoechoic glandular tissues, and discriminating entrapped fat lobules from isoechoic tumors. Furthermore, PDVF sonography was useful for determining whether intracystic echoes are attached to the cyst wall.
CONCLUSIONS: Power Doppler VF imaging is a valuable adjunct tool to B-mode sonography in the evaluation of breast lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16798901     DOI: 10.7863/jum.2006.25.7.897

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  Dynamic power Doppler ultrasonography of anterior abdominal wall hernias: confirmation of incarceration.

Authors:  Duzgun Yildirim; Baki Ekci; Bengi Gurses; Mutlu Sahin; Terman Gumus
Journal:  J Med Ultrason (2001)       Date:  2012-07-19       Impact factor: 1.314

2.  Additional role of colour Doppler ultrasound imaging in intracystic breast tumours.

Authors:  O Catalano; M Mattace Raso; M D'Aiuto; L A Illiano; P P Saturnino; A Siani
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.